Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

Clinical trial NCT02212561 · COMPLETED

Trial details

NCT number: NCT02212561
Sponsor: St. Jude Children's Research Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndrome (MDS)Mixed Phenotype Acute Leukemia (MPAL)

Start date: 2014-08-01
Primary completion: 2015-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.